SCHEMBL10060092

SCHEMBL10060092

CCc1ccc(-c2c3ccc(=O)cc-3oc3cc(O)ccc23)c(C(=O)O)c1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 3/20 0.72
▸ L3MBTL1 Q9Y468 1/20 0.72
▸ MEN1 O00255 2/20 0.60
▸ POLB P06746 2/20 0.60
▸ KMT2A Q03164 2/20 0.60
▸ ALPL P05186 1/20 0.60
▸ ALPI P09923 1/20 0.60
▸ ALPG P10696 1/20 0.60
▸ ESR1 P03372 1/20 0.59
▸ ATM Q13315 1/20 0.58
▸ PLEC Q15149 1/20 0.58
▸ CA9 Q16790 14/20 0.57
▸ CA1 P00915 12/20 0.57
▸ CA2 P00918 12/20 0.57
▸ CA12 O43570 4/20 0.57
▸ CA14 Q9ULX7 3/20 0.57
▸ CA7 P43166 3/20 0.55
▸ DNASE1L3 Q13609 1/20 0.54
▸ PRMT1 Q99873 1/20 0.54
▸ ALB P02768 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24594128 0.93 USP2 (0.64) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL20056705 0.90 USP2 (0.69) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL14619875 0.89 USP2 (0.72) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL13369020 0.89 USP2 (0.75) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL18383481 0.89 USP2 (0.68) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL29668458 0.89 USP2 (0.68) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL23318855 0.87 USP2 (0.66) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL10098714 0.86 USP2 (0.76) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL14563221 0.85 USP2 (0.69) USP2L3MBTL1MEN1POLBKMT2A
SCHEMBL12637647 0.85 USP2 (0.72) USP2L3MBTL1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210128591-A1 IONIC POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS SONY CORPORATION (JP) 2021-05-06 — — US disclosed
US-10688198-B2 Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof THE JOHNS HOPKINS UNIVERSITY (US) 2020-06-23 — — US disclosed
US-10434180-B2 Enzymatic conjugation of polypeptides INNATE PHARMA (FR) 2019-10-08 — — US disclosed
US-20120009121-A1 PSMA-TARGETING COMPOUNDS AND USES THEREOF THE JOHNS HOPKINS UNIVERSITY (US) 2012-01-12 — — US disclosed
US-20090156825-A1 Fluorescent compounds that bind to histone deacetylase MERCK SHARP & DOHME CORP. 2009-06-18 — — US disclosed
US-20070065898-A1 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor WYETH (US) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10688198-B2 Salicylic acid-based polymeric CEST contrast agents targeting prostate-specific membrane antigen and uses thereof KLK3, PSAT1, SPAG5 USP2 785/4885L3MBTL1 4066/4885MEN1 2155/4885
US-20120009121-A1 PSMA-TARGETING COMPOUNDS AND USES THEREOF FOLH1, KLK3, PSMA2 USP2 3252/4885L3MBTL1 2898/4885MEN1 190/4885
US-20090156825-A1 Fluorescent compounds that bind to histone deacetylase HDAC1, HDAC3, HDAC11 USP2 2116/4885L3MBTL1 1410/4885MEN1 3684/4885
US-10434180-B2 Enzymatic conjugation of polypeptides DNPEP, ENPEP, PEPD USP2 841/4885L3MBTL1 3802/4885MEN1 4381/4885
US-20070065898-A1 Fluorescence polarization assays for binding of caspase inhibitors and probes therefor APAF1, CASP1, CASP14 USP2 3883/4885L3MBTL1 1433/4885MEN1 2203/4885
US-20210128591-A1 IONIC POLYMERS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS TLN1, MRPL21, TLL1 USP2 4039/4885L3MBTL1 7/4885MEN1 120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback